J&J | JNJ - Creditori Commerciali





Creditori Commerciali Cambiamento Data
AbbVie USD 3.59B 28.65B 2025-12
Abbott USD 4.24B 117M 2025-12
Amgen USD 19.52B 1.37B 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
Baxter International USD 1.09B 87M 2026-03
Bayer EUR 6.59B 496M 2026-03
Becton, Dickinson and Co. USD 5.93B 204M 2026-03
Biogen USD 358.5M 73.5M 2026-03
Boston Scientific USD 1.14B 3M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
CONMED USD 105.42M 11.77M 2026-03
Cooper Companies USD 233.3M 7.5M 2026-03
Dexcom USD 1.94B 109.1M 2026-03
Edwards Lifesciences USD 181.1M 46.4M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Globus Medical USD 103.66M 4.81M 2026-03
Insulet USD 149.8M 74.8M 2026-03
Integra LifeSciences USD 87.95M 7.78M 2026-03
Intuitive Surgical USD 1.85B 68.6M 2026-03
J&J USD 10.46B 1.53B 2026-03
Medtronic USD 2.57B 12M 2025-12
Merck USD 3.86B 541M 2026-03
Merit Medical Systems USD 67.85M 7.3M 2026-03
Novartis USD 4.32B 134M 2026-03
Pfizer USD 4.51B 734M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sanofi EUR 22.71B 219M 2026-03
Stryker USD 1.8B 301M 2025-12
Tandem Diabetes Care USD 59.86M 12.79M 2026-03
Teva Pharmaceutical Industries USD 2.6B 65M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03
Zimmer Biomet Holdings USD 361.2M 58.2M 2026-03
Zoetis USD 507M 20M 2026-03